Company Filing History:
1 out of 1,736 
1 out of 2,930 
Years Active: 2023
Title: Innovations by Xiaofang Bian in Diabetes Diagnosis
Introduction
Xiaofang Bian is an accomplished inventor based in Mesa, Arizona. She has made significant contributions to the field of diabetes research, particularly in the early diagnosis and risk prediction of type 1 diabetes (T1D). Her innovative work has the potential to improve the lives of many individuals affected by this condition.
Latest Patents
Xiaofang Bian holds a patent for "Methods for diagnosis of type 1 diabetes." This patent identifies seventeen antigens as potential biomarkers for early detection and risk prediction of T1D. The antigens include MLH1, MTIF3, PPIL2, NUP50, TOX4, FIGN, C9orf142, ZNF280D, HES1, QRFPR, CTRC, SNX6, SYTL4, ELA2A, IGRP, PAX6, and HMGN3. This groundbreaking work aims to enhance the understanding and management of type 1 diabetes.
Career Highlights
Throughout her career, Xiaofang Bian has worked with prestigious institutions such as Arizona State University and the University of Florida Research Foundation. Her research has focused on identifying biomarkers that can lead to earlier and more accurate diagnoses of T1D.
Collaborations
Xiaofang has collaborated with notable professionals in her field, including Joshua LaBaer and Ji Qiu. These partnerships have contributed to the advancement of her research and the development of innovative diagnostic methods.
Conclusion
Xiaofang Bian's contributions to the field of diabetes diagnosis are invaluable. Her work on identifying biomarkers for type 1 diabetes has the potential to transform early detection and risk prediction, ultimately benefiting many patients.